Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 2003, p. 2688-2691, Vol. 47, No. 8
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.8.2688-2691.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Ultrastructure, Istituto Superiore di Sanità,1 Department of Public Health Sciences, University La Sapienza, Rome,3 Department of Experimental Medicine, II University of Naples, Naples, Italy2
Received 11 December 2002/ Returned for modification 17 March 2003/ Accepted 8 May 2003
We recently demonstrated that lactoferrin, an antimicrobial glycoprotein, can inhibit adenovirus infection by competing for common glycosaminoglycan receptors. This study further characterizes the antiadenovirus activity of the protein, thus demonstrating that lactoferrin neutralizes infection by binding to adenovirus particles and that its targets are viral III and IIIa structural polypeptides.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |